Corporate Governance
For a medical device maker, governance is both a matter of structure and a matter of who signs off a shipment and on what authority. We manage both in one framework.
Governance structure
General Meeting of Shareholders
Board of Directors4 directors
SupervisorIndependent audit
Representative Officer
Executive Officers
Quality AssuranceRelease authority
Internal Audit
The Quality Control Director decides release independently of sales and production. That authority cannot be overridden, including by the Representative Officer.
How the Board runs
| Frequency | Monthly as a rule, with extraordinary meetings as required |
|---|---|
| Composition | Four directors, with the Supervisor attending |
| Meetings in FY2026 | 14, with full attendance by every director |
| Standing items | Budget, capital expenditure, product recalls, serious defects, internal audit findings |
Compliance and risk
- Procedures under the Japanese PMD Act, GMP and ISO 13485 apply across every process.
- The whistleblowing line sits with an external law firm and does not identify the reporter.
- Serious defects reach the Quality Control Director and Representative Officer within 24 hours.
- Suppliers are audited annually and the results go to the Board.
Remuneration
| How it is set | Within the total approved by shareholders and agreed in Board discussion |
|---|---|
| Structure | 70% fixed, 30% performance linked |
| Performance measure | Consolidated operating profit and the number of serious defects |